Korona Virüs Tanısı ve Biyosensörler

Yıl 2022, Cilt: 31 Sayı: 4, 273 - 278, 30.12.2022

Umut Kökbaş

https://doi.org/10.17827/aktd.1117871

Öz

Hızla gelişen teknoloji dünyada dijitalleşme çağında laboratuvar tıbbının da bu gelişime ayak uydurarak sensör tabanlı ölçüm sistemlerinin kullanım alanları genişlemektedir. Biyosensörler kolay kullanımı, portatif olması, hızlı ve kesin sonuç vermesi gibi özelliklerinden dolayı salgın hastalık takibinde önemli rol oynayacaktır.
Çin'in Wuhan şehrinde 2019 yılında ortaya çıkan korona virüs hastalığı pandemi haline dönüşmüştür. Pandeminin takibi ve kontrolü için tanı testleri geliştirilmesi ve tanı testlerinde kullanılacak örnek seçimi büyük önem kazanmıştır.
Bu derlemede korona virüs hastalığının tanı ve takibinin günümüzde nasıl yapıldığı hakkında bilgi verip biyosensörlerin tanı ve takip amacıyla kullanılabilirliği hakkında bilgiler verilmektedir.

Anahtar Kelimeler

Covid-19, Biyosensör, Korona Virüs

Corona Virus Diagnosis and Biosensors

Öz

In the age of digitalization in the rapidly developing technology world, the usage areas of sensor-based measurement systems are expanding by keeping up with this development in laboratory medicine. Biosensors will play an important role in the follow-up of epidemic diseases due to their features such as easy use, portability, fast and precise results.
The corona virus disease, which emerged in 2019 in the city of Wuhan, China, has turned into a pandemic. The development of diagnostic tests for the follow-up and control of the pandemic and the selection of samples to be used in diagnostic tests have gained great importance.
In this review, information is given about how the diagnosis and follow-up of the corona virus disease is done today, and information about the usability of biosensors for diagnosis and follow-up.

Anahtar Kelimeler

Covid-19, Biosensor, Corona Virus

Kaynakça

• 1. Mugweru, A., B.L. Clark, and M.V. Pishko. Electrochemical sensor array for glucose monitoring fabricated by rapid immobilization of active glucose oxidase within photochemically polymerized hydrogels. J Diabetes Sci Technol. 2007;1:366-71.
• 2. Kökbaş, U., L. KAYRIN, and T. Abdullah. Biyosensörler ve tıpta kullanım alanları. Arşiv Kaynak Tarama Dergisi. 2013;22:499-513.
• 3. Harun-Ur-Rashid, M., T. Foyez, I. Jahan, K. Pal, and A.B. Imran. Rapid diagnosis of COVID-19 via nano-biosensor-implemented biomedical utilization: a systematic review. RSC Adv. 2022;12:9445-9465.
• 4. Yasri, S. and V. Wiwanitkit. Sustainable materials and COVID-19 detection biosensor: A brief review. Sens Int. 2022;3:100171.
• 5. Kim, H.E., A. Schuck, S.H. Lee, Y. Lee, M. Kang, and Y.S. Kim. Sensitive electrochemical biosensor combined with isothermal amplification for point-of-care COVID-19 tests. Biosens Bioelectron. 2021;182:113168.
• 6. Corman, V.M., H.F. Rabenau, O. Adams, D. Oberle, M.B. Funk, B. Keller-Stanislawski, et al. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission. Transfusion. 2020;60:1119-1122.
• 7. Eser, F., B. Kayaaslan, R. Guner, I. Hasanoglu, A. Kaya Kalem, A. Aypak, et al. The Effect of prolonged PCR Positivity on patient Outcomes and Determination of Isolation period in COVID-19 patients. Int J Clin Pract. 2021;75:e14025.
• 8. Brogna, B., C. Brogna, M. Petrillo, A.M. Conte, G. Benincasa, L. Montano, et al. SARS-CoV-2 Detection in Fecal Sample from a Patient with Typical Findings of COVID-19 Pneumonia on CT but Negative to Multiple SARS-CoV-2 RT-PCR Tests on Oropharyngeal and Nasopharyngeal Swab Samples. Medicina (Kaunas). 2021;57:
• 9. Wolfel, R., V.M. Corman, W. Guggemos, M. Seilmaier, S. Zange, M.A. Muller, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465-469.
• 10. Guclu, E., M. Koroglu, Y. Yurumez, H. Toptan, E. Kose, F. Guneysu, et al. Comparison of saliva and oro-nasopharyngeal swab sample in the molecular diagnosis of COVID-19. Rev Assoc Med Bras (1992). 2020;66:1116-1121.
• 11. Barrera-Avalos, C., R. Luraschi, E. Vallejos-Vidal, M. Figueroa, E. Arenillas, D. Barria, et al. Analysis by real-time PCR of five transport and conservation mediums of nasopharyngeal swab samples to COVID-19 diagnosis in Santiago of Chile. J Med Virol. 2021;
• 12. Sakanashi, D., N. Asai, A. Nakamura, N. Miyazaki, Y. Kawamoto, T. Ohno, et al. Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19. J Infect Chemother. 2021;27:126-129.
• 13. Chambers, C., P. Krogstad, K. Bertrand, D. Contreras, N.H. Tobin, L. Bode, et al. Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women. JAMA. 2020;324:1347-1348.
• 14. Wang, W., Y. Xu, R. Gao, R. Lu, K. Han, G. Wu, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020;323:1843-1844.
• 15. Wang, A.J., Y.F. Li, Z.H. Li, J.J. Feng, Y.L. Sun, and J.R. Chen. Amperometric glucose sensor based on enhanced catalytic reduction of oxygen using glucose oxidase adsorbed onto core-shell Fe3O4@silica@Au magnetic nanoparticles. Mater Sci Eng C Mater Biol Appl. 2012;32:1640-7.
• 16. Chang, L., L. Zhao, H. Gong, L. Wang, and L. Wang. Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations. Emerg Infect Dis. 2020;26:1631-1633.
• 17. Kwon, S.Y., E.J. Kim, Y.S. Jung, J.S. Jang, and N.S. Cho. Post-donation COVID-19 identification in blood donors. Vox Sang. 2020;115:601-602.
• 18. Dong, Y., X. Chi, H. Hai, L. Sun, M. Zhang, W.F. Xie, et al. Antibodies in the breast milk of a maternal woman with COVID-19. Emerg Microbes Infect. 2020;9:1467-1469.
• 19. Loeffelholz, M.J. and Y.W. Tang. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020;9:747-756.
• 20. Castanheira, J., A. Mascarenhas Gaivao, S. Mairos Teixeira, P.J. Pereira, and D.C. Costa. Asymptomatic COVID-19 positive patient suspected on FDG-PET/CT. Nucl Med Commun. 2020;41:598-599.
• 21. Al-Zoubi, N.A., B.R. Obeidat, M.A. Al-Ghazo, W.A. Hayajneh, A.H. Alomari, T.S. Mazahreh, et al. Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study. Ann Med Surg (Lond). 2020;57:14-16.
• 22. Kaneko, Y., A. Sugiyama, T. Tanaka, K. Fukui, A. Taguchi, K. Tatsuno, et al. The serological diversity of serum IgG/IgA/IgM against SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan. Health Sci Rep. 2022;5:e572.
• 23. Calvo-Lozano, O., M. Sierra, M. Soler, M.C. Estevez, L. Chiscano-Camon, A. Ruiz-Sanmartin, et al. Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical Validation. Anal Chem. 2022;94:975-984.
• 24. Cady, N.C., N. Tokranova, A. Minor, N. Nikvand, K. Strle, W.T. Lee, et al. Multiplexed detection and quantification of human antibody response to COVID-19 infection using a plasmon enhanced biosensor platform. Biosens Bioelectron. 2021;171:112679.
• 25. Krupski, W., A. Gorecki, and J. Kruk-Bachonko. Diagnostic value of chest CT scanning for determination of Covid-19 severity in individual lung lobes. Ann Agric Environ Med. 2022;29:115-119.
• 26. Taha, B.A., Y. Al Mashhadany, M.H. Hafiz Mokhtar, M.S. Dzulkefly Bin Zan, and N. Arsad. An Analysis Review of Detection Coronavirus Disease 2019 (COVID-19) Based on Biosensor Application. Sensors (Basel). 2020;20:
• 27. Perez-Garcia, F., J. Romanyk, H. Moya Gutierrez, A. Labrador Ballestero, I. Perez Ranz, J. Gonzalez Arroyo, et al. Comparative evaluation of Panbio and SD Biosensor antigen rapid diagnostic tests for COVID-19 diagnosis. J Med Virol. 2021;93:5650-5654.
• 28. Parihar, A., P. Ranjan, S.K. Sanghi, A.K. Srivastava, and R. Khan. Point-of-Care Biosensor-Based Diagnosis of COVID-19 Holds Promise to Combat Current and Future Pandemics. ACS Appl Bio Mater. 2020;3:7326-7343.